135 related articles for article (PubMed ID: 24071373)
1. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone.
Tang ZL; Zhang WJ; Wang DX; Chen JM; Ma H; Wu DR
J Oral Maxillofac Surg; 2014 Feb; 72(2):419-30. PubMed ID: 24071373
[TBL] [Abstract][Full Text] [Related]
2. Effect of intermittent systemic administration of recombinant parathyroid hormone (1-34) on mandibular fracture healing in rats.
Rowshan HH; Parham MA; Baur DA; McEntee RD; Cauley E; Carriere DT; Wood JC; Demsar WJ; Pizarro JM
J Oral Maxillofac Surg; 2010 Feb; 68(2):260-7. PubMed ID: 20116693
[TBL] [Abstract][Full Text] [Related]
3. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis.
Tokunaga K; Seto H; Ohba H; Mihara C; Hama H; Horibe M; Yoneda S; Nagata T
J Periodontal Res; 2011 Dec; 46(6):655-62. PubMed ID: 21722135
[TBL] [Abstract][Full Text] [Related]
4. Intermittent parathyroid hormone administration improves periodontal healing in rats.
Vasconcelos DF; Marques MR; Benatti BB; Barros SP; Nociti FH; Novaes PD
J Periodontol; 2014 May; 85(5):721-8. PubMed ID: 23895251
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of parathyroid hormone bound to a synthetic matrix for guided bone regeneration around dental implants: a histomorphometric study in dogs.
Valderrama P; Jung RE; Thoma DS; Jones AA; Cochran DL
J Periodontol; 2010 May; 81(5):737-47. PubMed ID: 20429653
[TBL] [Abstract][Full Text] [Related]
6. Role of parathyroid hormone therapy in reversing radiation-induced nonunion and normalization of radiomorphometrics in a murine mandibular model of distraction osteogenesis.
Gallagher KK; Deshpande S; Tchanque-Fossuo CN; Donneys A; Sarhaddi D; Nelson NS; Chepeha DB; Buchman SR
Head Neck; 2013 Dec; 35(12):1732-7. PubMed ID: 23335324
[TBL] [Abstract][Full Text] [Related]
7. Alveolar bone regeneration in response to local application of calcitriol in vitamin D deficient rats.
Fügl A; Gruber R; Agis H; Lzicar H; Keibl C; Schwarze UY; Dvorak G
J Clin Periodontol; 2015 Jan; 42(1):96-103. PubMed ID: 25469560
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
[TBL] [Abstract][Full Text] [Related]
9. Effect of calcitonin on bone regeneration in male rats: a histomorphometric analysis.
Almeida JD; Arisawa EA; da Rocha RF; Carvalho YR
Int J Oral Maxillofac Surg; 2007 May; 36(5):435-40. PubMed ID: 17275259
[TBL] [Abstract][Full Text] [Related]
10. [Intermittent low-dose administration of recombinant human parathyroid hormone (1-34) promotes the expression of Runx2 during early stage of fracture healing].
Li N; Wang MY; He L; Jiang X; Wu CA
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):771-6. PubMed ID: 19595108
[TBL] [Abstract][Full Text] [Related]
11. The effect of matrix bound parathyroid hormone on bone regeneration.
Jung RE; Cochran DL; Domken O; Seibl R; Jones AA; Buser D; Hammerle CH
Clin Oral Implants Res; 2007 Jun; 18(3):319-25. PubMed ID: 17386063
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.
Morgan EF; Mason ZD; Bishop G; Davis AD; Wigner NA; Gerstenfeld LC; Einhorn TA
Bone; 2008 Dec; 43(6):1031-8. PubMed ID: 18761113
[TBL] [Abstract][Full Text] [Related]
13. The rhPTH (1-34), but not elcatonin, increases bone anabolic efficacy in postmenopausal women with osteoporosis.
Zhang L; Yang M; Liu D; Guo C; Li L; Yang G
Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):361-6. PubMed ID: 22639400
[TBL] [Abstract][Full Text] [Related]
14. Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits.
Pampu AA; Dolanmaz D; Tüz HH; Avunduk MC; Kişnişci RS
J Oral Maxillofac Surg; 2008 May; 66(5):905-10. PubMed ID: 18423279
[TBL] [Abstract][Full Text] [Related]
15. [Repair of articular cartilage defect with poly-lactide-co-glycolide loaded with recombinant human bone morphogenetic protein in rabbits].
Cui Y; Wu J; Hu Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1233-7. PubMed ID: 18069483
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model.
O'Loughlin PF; Cunningham ME; Bukata SV; Tomin E; Poynton AR; Doty SB; Sama AA; Lane JM
Spine (Phila Pa 1976); 2009 Jan; 34(2):121-30. PubMed ID: 19112335
[TBL] [Abstract][Full Text] [Related]
17. Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs.
Yao Y; Wang G; Wang Z; Wang C; Zhang H; Liu C
J Oral Maxillofac Surg; 2011 Nov; 69(11):e446-55. PubMed ID: 22018252
[TBL] [Abstract][Full Text] [Related]
18. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling.
Higuchi T; Kinoshita A; Takahashi K; Oda S; Ishikawa I
J Periodontol; 1999 Sep; 70(9):1026-31. PubMed ID: 10505805
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human erythropoietin on mandibular distraction osteogenesis.
Mihmanli A; Dolanmaz D; Avunduk MC; Erdemli E
J Oral Maxillofac Surg; 2009 Nov; 67(11):2337-43. PubMed ID: 19837300
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma.
Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Biondi B; Iorio S; Giustina A; Amato G; Carella C
J Bone Miner Res; 2005 Mar; 20(3):480-6. PubMed ID: 15746993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
